VSTM Verastem, Inc. - Common Stock
$7,51
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 6, 2026
52W-Spanne
$3–$11
52% of range
Analystenbewertung
BUY
15 analysts
Kursziel
$15
+96% upside
P/E (TTM)
-2.5
ROE
-449.2%
Nettogewinnmarge
-677.6%
VSTM Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$7.51
Marktkapitalisierung
$584M
P/E (TTM)
-2.5
EPS (TTM)
$-3.02
Umsatz (TTM)
$31M
Dividendenrendite
—
ROE
-449.2%
Verschuldungsgrad
—
52W-Spanne
$3 – $11
VSTM Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$31M
2018-12-31
→
2025-12-31
EPS
$-3.02
2016-12-31
→
2025-12-31
Freier Cashflow
—
2016-12-31
→
2024-12-31
Margen
-677.6%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
VSTM
Peer-Median
P/E (TTM)
-2.5
19.6
P/S (TTM) (K/V (TTM))
18.9
24.9
P/B (K/B)
10.2
3.1
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
VSTM
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-550.3%
—
Net Profit Margin (Nettogewinnmarge)
-677.6%
-298.0%
ROA
-120.4%
-56.6%
ROE
-449.2%
-70.8%
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
VSTM
Peer-Median
Current Ratio (Liquiditätsgrad)
3.1
5.2
Quick Ratio
2.8
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
VSTM
Peer-Median
Revenue YoY (Umsatz YoY)
209.1%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
128.4%
—
Revenue CAGR 5Y (Umsatz CAGR 5J)
-19.0%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
VSTM
Peer-Median
VSTM Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
15 Analysten
- Starker Kauf 5 33,3%
- Kauf 9 60,0%
- Halten 1 6,7%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
8 Analysten · 2026-08-13
Median
$15.00
← Unter allen Zielen
$7.51
Tief
$9.00
Hoch
$18.00
Median-Ziel
$15.00
+99,7%
Mittelwert-Ziel
$14.75
+96,4%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-0.04%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.35 | $-0.44 | 0.09% |
| 31. März 2026 | $-0.46 | $-0.47 | 0.01% |
| 31. Dezember 2025 | $-0.50 | $-0.55 | 0.05% |
| 30. September 2025 | $-1.35 | $-0.65 | -0.70% |
| 30. Juni 2025 | $-0.39 | $-0.76 | 0.37% |
| 31. März 2025 | $-0.79 | $-0.73 | -0.06% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| VSTM | $600M | -2.6 | 209.1% | -677.6% | -449.2% | — |
| KYTX | $568M | -2.6 | — | — | -77.4% | — |
| PRLD | — | -2.2 | 73.4% | -819.6% | -137.7% | — |
| CCCC | $185M | -1.5 | 1.0% | -292.1% | -48.8% | — |
| EVMN | $540M | -1.5 | 85.7% | -529.8% | -401.2% | — |
| ZURA | — | — | — | — | — | — |
| CABA | $220M | -1.0 | — | — | -115.5% | — |
| MPLT | $773M | -0.9 | — | — | -151.1% | — |
| EDIT | $201M | -1.1 | 25.4% | -395.0% | -688.8% | — |
| PBYI | $300M | 9.8 | -0.91% | 13.6% | 26.5% | — |
| OCGN | $422M | -5.6 | 8.8% | -1537.4% | 1488.8% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 17
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $31M | $10M | · | $3M | $2M | $89M | $17M | $27M | |
| Cost of Revenue | · | · | · | · | · | · | · | $165.0K | |
| R&D Expense | $115M | $81M | $61M | $51M | $39M | $41M | $46M | $44M | |
| SG&A Expense | $81M | $44M | $31M | $25M | $24M | $63M | $101M | $77M | |
| Operating Expenses | $201M | $125M | $92M | $76M | $63M | $138M | $150M | $122M | |
| Operating Income | $-170M | $-115M | $-92M | $-73M | $-61M | $-49M | $-132M | $-95M | |
| Interest Expense | $1M | $5M | $4M | $2M | $10M | $16M | $21M | $6M | |
| Interest Income | $4M | $4M | $6M | $1M | $181.0K | $515.0K | $4M | $3M | |
| Other Non-op | $-203.0K | $-123.0K | $-109.0K | $47.0K | · | $-1M | $-641.0K | $26M | |
| Pretax Income | $-209M | $-130M | $-87M | $-74M | $-71M | $-68M | $-149M | $-72M | |
| Income Tax | · | $185.0K | · | $0 | $0 | $194.0K | $0 | $0 | |
| Net Income | $-209M | $-131M | $-87M | $-74M | $-71M | $-68M | $-149M | $-72M | |
| EPS (Basic) | $-3.02 | $-3.66 | $-3.96 | $-4.57 | $-4.90 | $-0.44 | $-2.00 | $-1.12 | |
| EPS (Diluted) | $-3.02 | $-3.66 | $-3.96 | $-4.57 | $-4.90 | $-0.44 | $-2.00 | $-1.37 | |
| Shares (Basic) | 69,309,000 | 35,713,000 | 22,054,000 | 16,138,000 | 14,535,000 | 153,330,000 | 74,578,000 | 64,962,000 | |
| Shares (Diluted) | 69,309,000 | 35,713,000 | 22,054,000 | 16,138,000 | 14,535,000 | 153,330 | 74,578,000 | 69,321,000 | |
| EBITDA | $-170M | $-115M | $-92M | $-73M | $-61M | $-49M | $-132M | $-95M |
Bilanz 23
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $205M | $89M | $78M | $75M | $21M | $68M | $44M | $130M | |
| Inventory | $2M | · | · | · | · | · | $3M | $327.0K | |
| Prepaid Expense | $8M | $6M | $7M | $5M | $5M | $3M | $4M | $3M | |
| Current Assets | $223M | $95M | $144M | $93M | $106M | $145M | $85M | $253M | |
| PP&E (Net) | · | $32.0K | $37.0K | $92.0K | $210.0K | $416.0K | $947.0K | $1M | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $2M | $1M | $938.0K | $509.0K | |
| Intangibles | $16M | · | · | · | · | · | $20M | $22M | |
| Other Non-current Assets | $6M | $5M | $5M | $58.0K | $169.0K | $33.0K | $812.0K | $790.0K | |
| Total Assets | $246M | $102M | $150M | $95M | $109M | $154M | $145M | $277M | |
| Accounts Payable | $12M | $4M | $7M | $5M | $2M | $2M | $10M | $10M | |
| Accrued Liabilities | $54M | $26M | $18M | $15M | $16M | $15M | $19M | $21M | |
| Current Liabilities | $72M | $31M | $26M | $22M | $19M | $17M | $30M | $37M | |
| Capital Leases | · | $535.0K | $530.0K | $1M | $2M | $3M | $3M | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | $870.0K | $1M | |
| Total Liabilities | $189M | $130M | $71M | $48M | $21M | $39M | $138M | $153M | |
| Long-term Debt | · | $41M | $40M | $25M | · | · | $35M | $25M | |
| Common Stock | $8.0K | $4.0K | $3.0K | $2.0K | $19.0K | $17.0K | $8.0K | $7.0K | |
| Retained Earnings | $-1.16B | $-956M | $-825M | $-738M | $-664M | $-593M | $-525M | $-376M | |
| AOCI | $5M | · | $13.0K | · | $34.0K | $53.0K | $14.0K | $127.0K | |
| Stockholders' Equity | $57M | $-29M | $57M | $47M | $88M | $115M | $7M | $124M | |
| Liabilities + Equity | $246M | $102M | $150M | $95M | $109M | $154M | $145M | $277M | |
| Shares Outstanding | 77,740,000 | 44,784,000 | 25,281,000 | 16,712,000 | 185,286,000 | 170,456,000 | 80,118,000 | 73,806,000 |
Cashflow 15
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $9M | $7M | $6M | $6M | $8M | $8M | $9M | $7M | |
| Deferred Tax | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Amort. of Intangibles | $698.0K | · | · | · | · | $793.0K | $2M | $423.0K | |
| Restructuring | · | · | · | · | $0 | $5M | · | · | |
| Operating Cash Flow | $-138M | $-105M | $-86M | $-64M | $-54M | $-34M | $-139M | $-75M | |
| CapEx | · | $28.0K | · | · | $196.0K | $33.0K | $7.0K | $2M | |
| Investing Cash Flow | $-10M | $60M | $-44M | $66M | $87.0K | $-47M | $90M | $-138M | |
| Net Debt Issued | $-43M | · | $-300.0K | · | · | $-37M | · | · | |
| Stock Issued | $197M | $14M | $91M | $27M | $7M | $106M | · | $105M | |
| Net Stock Activity | $197M | $14M | $91M | $27M | $7M | $106M | · | · | |
| Financing Cash Flow | $263M | $55M | $134M | $52M | $7M | $70M | $-2M | $261M | |
| Net Change in Cash | $116M | $10M | $3M | $54M | $-47M | $-11M | $-51M | $48M | |
| Taxes Paid | $185.0K | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $-105M | · | · | $-54M | $-34M | $-139M | $-76M | |
| Levered FCF | · | $-109M | · | · | $-64M | $-49M | · | · |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -550.3% | -1149.6% | · | -2809.6% | -2991.2% | -55.8% | -758.1% | -354.8% | |
| Net Margin | -677.6% | -1306.4% | · | -2843.3% | -3468.1% | -76.5% | -854.8% | -271.1% | |
| Pretax Margin | -677.6% | -1304.5% | · | -2843.3% | -3468.1% | -76.3% | · | · | |
| EBITDA Margin | -550.3% | -1149.6% | · | -2809.6% | -2991.2% | -55.8% | -758.1% | -354.8% | |
| ROA | -120.4% | -104.0% | -71.4% | -72.5% | -54.1% | -45.2% | -70.7% | -39.5% | |
| ROE | -449.2% | 1465.1% | -124.3% | -133.9% | -77.7% | -55.3% | -1040.1% | -62.5% | |
| ROIC | · | 398.4% | · | -153.9% | -70.1% | -42.9% | · | · |
Liquidität & Solvenz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.1 | 3.1 | 5.4 | 4.3 | 5.7 | 8.5 | 2.8 | 6.8 | |
| Quick Ratio | 2.8 | 2.9 | 3.0 | 3.5 | 1.1 | 4.0 | 1.5 | 3.5 | |
| Interest Coverage | -149.5 | -25.2 | -22.2 | -34.1 | -6.2 | -3.1 | -6.4 | -16.3 |
Effizienz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | · | 0.0 | 0.0 | 0.6 | 0.1 | 0.1 | |
| Inventory Turnover | · | · | · | · | · | · | · | 1.0 |
Wachstumsraten 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 209.1% | · | · | 26.5% | -97.7% | · | · | · | |
| Revenue CAGR 3Y | 128.4% | 69.5% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -19.0% | · | · | · | · | · | · | · |
Bewertung (TTM) 10
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $31M | $10M | $4M | $3M | $2M | $89M | $17M | $27M | |
| Net Income TTM | $-209M | $-131M | $-87M | $-74M | $-71M | $-68M | $-149M | $-72M | |
| Market Cap | $600M | $232M | $206M | $963M | $4.56B | $4.36B | $1.29B | $2.98B | |
| P/E | -2.6 | -1.4 | -2.1 | -1.1 | -5.0 | -58.1 | -8.0 | -29.4 | |
| P/S | 19.4 | 23.2 | 50.1 | 370.8 | 2220.2 | 49.2 | 73.8 | 111.4 | |
| P/B | 10.5 | -8.0 | 3.6 | 20.3 | 52.1 | 37.8 | 179.6 | 23.9 | |
| P / Tangible Book | 14.7 | · | 3.6 | 20.3 | 52.1 | 37.8 | · | · | |
| P / Cash Flow | -4.4 | -2.2 | -2.4 | -15.1 | -85.2 | -130.0 | -9.3 | -39.9 | |
| P / FCF | · | -2.2 | · | · | -84.9 | -129.9 | -9.3 | -39.1 | |
| Earnings Yield | -39.1% | -70.8% | -48.6% | -95.2% | -19.9% | -1.7% | -12.4% | -3.4% |
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $40M | $19M | $18M | $11M | $2M | · | $0 | $0 | $10M | · | · | · | · | $0 | $0 | $0 | |
| R&D Expense | $41M | $38M | $32M | $29M | $25M | $29M | $21M | $25M | $18M | $18M | $14M | $13M | $12M | $11M | $11M | $15M | |
| SG&A Expense | $27M | $22M | $24M | $21M | $21M | $15M | $11M | $12M | $10M | $10M | $7M | $7M | $7M | $6M | $6M | $7M | |
| Operating Expenses | $73M | $64M | $59M | $52M | $46M | $44M | $32M | $37M | $28M | $28M | $21M | $20M | $19M | $17M | $18M | $21M | |
| Operating Income | $-33M | $-45M | $-41M | $-41M | $-44M | $-44M | $-32M | $-37M | $-18M | $-28M | $-21M | $-20M | $-19M | $-17M | $-18M | $-21M | |
| Interest Expense | $360.0K | $382.0K | $415.0K | $319.0K | $212.0K | $192.0K | $1M | $1M | $1M | $1M | $1M | $1M | $769.0K | $724.0K | $717.0K | $640.0K | |
| Interest Income | $1M | $1M | $1M | $1M | $822.0K | $960.0K | $968.0K | $831.0K | $983.0K | $1M | $2M | $1M | $976.0K | $769.0K | $316.0K | $84.0K | |
| Other Non-op | $-52.0K | $-61.0K | $-16.0K | $-37.0K | $-110.0K | $-40.0K | $8.0K | $-77.0K | $-24.0K | $-30.0K | $-13.0K | $-40.0K | $-7.0K | $-7.0K | $20.0K | $6.0K | |
| Pretax Income | $-34M | · | · | · | $-26M | · | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | $816.0K | $0 | · | $0 | $0 | $0 | $185.0K | $0 | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | |
| Net Income | $-35M | $-37M | $-33M | $-99M | $-26M | $-52M | $-65M | $-24M | $-8M | $-34M | $-20M | $-24M | $-16M | $-17M | $-18M | $-22M | |
| EPS (Basic) | $-0.35 | $-0.37 | $-0.32 | $-1.35 | $-0.39 | $-0.96 | $-1.49 | $-0.60 | $-0.31 | $-1.26 | $-0.75 | $-1.37 | $-0.94 | $-1.97 | $-1.10 | $-1.41 | |
| EPS (Diluted) | $-0.35 | $-0.46 | $-0.09 | $-1.35 | $-0.62 | $-0.96 | $-1.49 | $-0.60 | $-0.31 | $-1.26 | $-0.75 | $-1.37 | $-0.08 | $-4.27 | $-0.09 | $-0.12 | |
| Shares (Basic) | 100,116,000 | 98,292,000 | -124,164,000 | 73,157,000 | 66,143,000 | 54,173,000 | -58,238,000 | 40,258,000 | 26,861,000 | 26,832,000 | 26,790,000 | 17,732,000 | 16,723,000 | -202,095,000 | 16,430,000 | 15,539,000 | |
| Shares (Diluted) | 100,116,000 | 99,148,000 | -132,058,000 | 73,157,000 | 74,037,000 | 54,173,000 | -58,238,000 | 40,258,000 | 26,861,000 | 26,832,000 | 26,790,000 | · | 200,679,000 | -553,740,000 | 197,151,000 | 186,463,000 | |
| EBITDA | $-33M | $-45M | · | $-41M | $-44M | $-44M | · | $-37M | $-18M | $-28M | $-21M | $-20M | $-19M | · | $-18M | $-21M |
Bilanz 26
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $136M | $166M | $205M | $138M | $164M | $118M | $89M | $113M | $83M | $81M | $95M | $183M | $97M | · | $78M | $64M | |
| Short-term Investments | · | $16M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Inventory | $2M | $2M | $2M | $2M | $1M | · | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $8M | $9M | $8M | $8M | $7M | $7M | $6M | $7M | $5M | $7M | $9M | $7M | $8M | · | $5M | $3M | |
| Current Assets | $176M | $203M | $223M | $154M | $174M | $125M | $95M | $121M | $100M | $118M | $174M | $190M | $119M | · | $109M | $98M | |
| PP&E (Net) | · | · | · | $20.0K | $21.0K | $22.0K | $32.0K | $39.0K | $46.0K | $52.0K | $35.0K | $40.0K | $62.0K | · | $121.0K | $151.0K | |
| PP&E (Gross) | · | · | $2M | · | · | · | $2M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $2M | · | · | · | $2M | · | · | · | · | · | · | · | · | · | |
| Intangibles | $16M | $16M | $16M | $17M | $16M | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $12M | $6M | $6M | $5M | $5M | $6M | $5M | $5M | $5M | $5M | $56.0K | $20.0K | $36.0K | · | $47.0K | $84.0K | |
| Total Assets | $207M | $228M | $246M | $177M | $196M | $132M | $102M | $126M | $106M | $124M | $176M | $192M | $121M | · | $111M | $100M | |
| Accounts Payable | $18M | $10M | $12M | $10M | $8M | $7M | $4M | $4M | $7M | $7M | $5M | $5M | $5M | · | $5M | $2M | |
| Accrued Liabilities | $54M | $51M | $54M | $45M | $38M | $25M | $26M | $22M | $17M | $17M | $16M | $14M | $14M | · | $15M | $18M | |
| Short-term Debt | $214.0K | $529.0K | · | $188.0K | $467.0K | $740.0K | · | $133.0K | $526.0K | $911.0K | $146.0K | $579.0K | $1M | · | · | · | |
| Current Liabilities | $78M | $67M | $72M | $60M | $50M | $36M | $31M | $37M | $30M | $27M | $24M | $21M | $22M | · | $22M | $20M | |
| Capital Leases | $2M | $2M | · | · | · | $271.0K | $535.0K | · | · | $270.0K | $780.0K | $1M | $1M | · | $2M | $2M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | $51.0K | · | · | · | · | · | |
| Total Liabilities | $157M | $146M | $189M | $192M | $160M | $164M | $130M | $94M | $66M | $77M | $72M | $69M | $67M | · | $48M | $47M | |
| Long-term Debt | · | · | · | · | · | · | $41M | $41M | $40M | $40M | $40M | $40M | $40M | · | $24M | $24M | |
| Total Debt | $214.0K | $529.0K | · | $188.0K | $467.0K | $740.0K | · | $133.0K | · | $911.0K | $146.0K | $579.0K | $1M | · | · | · | |
| Common Stock | $9.0K | $9.0K | $8.0K | $7.0K | $6.0K | $5.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $20.0K | · | $21.0K | $19.0K | |
| Retained Earnings | $-1.24B | $-1.20B | $-1.16B | $-1.13B | $-1.03B | $-1.01B | $-956M | $-891M | $-867M | $-859M | $-798M | $-778M | $-753M | · | $-721M | $-703M | |
| AOCI | $8M | $9M | $5M | $3M | $5M | $7M | · | · | · | $-4.0K | $49.0K | $1.0K | $6.0K | · | $-39.0K | $-130.0K | |
| Stockholders' Equity | $50M | $82M | $57M | $-16M | $36M | $-32M | $-29M | $11M | $19M | $25M | $83M | $102M | $33M | $47M | $63M | $54M | |
| Liabilities + Equity | $207M | $228M | $246M | $177M | $196M | $132M | $102M | $126M | $106M | $124M | $176M | $192M | $121M | · | $111M | $100M | |
| Shares Outstanding | 90,482,000 | 87,843,000 | 77,740,000 | 66,749,000 | 61,523,000 | 51,490,000 | 44,784,000 | 40,262,000 | 26,876,000 | 25,308,000 | 25,265,000 | 25,242,000 | 200,541,000 | · | 210,084,000 | 187,613,000 |
Cashflow 11
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $1M | $2M | $1M | $1M | $1M | $1M | $2M | |
| Amort. of Intangibles | $280.0K | $279.0K | $280.0K | $290.0K | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-44M | $-52M | $-30M | $-36M | $-33M | $-39M | $-25M | $-24M | $-28M | $-28M | $-17M | $-20M | $-20M | $-17M | $-15M | $-13M | |
| CapEx | · | · | · | · | · | · | $0 | $0 | $7.0K | $21.0K | · | · | · | · | · | · | |
| Investing Cash Flow | $16M | $-16M | $-1M | · | · | · | $0 | $0 | $29M | $31M | $-70M | $14M | $-804.0K | $13M | $5M | $29M | |
| Net Debt Issued | · | · | · | · | · | $-43M | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | · | · | $97M | $0 | $70M | $30M | $0 | · | · | · | $-486.0K | · | · | $0 | $26M | $1M | |
| Net Stock Activity | · | · | · | · | · | $30M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-2M | $29M | $99M | $18M | $79M | $67M | $742.0K | $54M | $-405.0K | $846.0K | $-891.0K | $91M | $44M | $0 | $26M | $708.0K | |
| Net Change in Cash | $-29M | $-39M | $67M | $-27M | $47M | $29M | $-24M | $30M | $1M | $4M | $-88M | $86M | $23M | $-4M | $15M | $17M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-28M | · | · | · | · | · | · |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -81.6% | -240.5% | · | -362.2% | -2047.9% | · | · | · | -182.8% | · | · | · | · | · | · | · | |
| Net Margin | -86.5% | -196.0% | · | -876.3% | -1213.6% | · | · | · | -82.6% | · | · | · | · | · | · | · | |
| Pretax Margin | -84.5% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -81.6% | -240.5% | · | -362.2% | -2047.9% | · | · | · | -182.8% | · | · | · | · | · | · | · | |
| ROA | -17.2% | -20.4% | · | -65.0% | -13.4% | -43.9% | · | -15.8% | · | -27.7% | -13.9% | -16.6% | -13.3% | · | -16.2% | -19.6% | |
| ROE | -80.6% | -148.3% | · | 4411.9% | -37.7% | 767.2% | · | -50.9% | · | -116.6% | -27.4% | -31.2% | -29.7% | · | -22.8% | -30.9% | |
| ROIC | -66.7% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Liquidität & Solvenz 4
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.3 | 3.0 | · | 2.6 | 3.5 | 3.5 | · | 3.2 | · | 4.4 | 7.3 | 9.1 | 5.3 | · | 5.0 | 4.9 | |
| Quick Ratio | 1.7 | 2.7 | · | 2.3 | 3.3 | 3.3 | · | 3.0 | · | 3.0 | 4.0 | 8.8 | 4.3 | · | 3.6 | 3.2 | |
| Debt / Equity | 0.0 | 0.0 | · | -0.0 | 0.0 | -0.0 | · | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | · | · | · | |
| Interest Coverage | -90.9 | -117.5 | · | -127.6 | -206.4 | -230.1 | · | -32.3 | -16.1 | -24.8 | -18.9 | -18.1 | -25.2 | · | -24.7 | -33.4 |
Effizienz 1
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | · | 0.1 | 0.0 | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $72M | · | · | · | · | · | · | · | · | $4M | $4M | $4M | $4M | · | $4M | $4M | |
| Net Income TTM | $-196M | $-213M | · | $-201M | $-110M | $-118M | · | $-86M | $-86M | $-94M | $-78M | $-80M | $-73M | · | $-80M | $-79M | |
| Market Cap | $346M | $466M | · | $589M | $255M | $310M | · | $120M | · | $299M | $205M | $188M | $1.01B | · | $2.14B | $2.61B | |
| Enterprise Value | $210M | $284M | · | $452M | $91M | $194M | · | $7M | · | $218M | $111M | $5M | $914M | · | · | · | |
| P/E | -1.4 | -1.6 | · | -2.5 | -1.7 | -1.9 | · | -1.0 | -0.8 | -3.4 | -3.6 | -4.5 | -13.3 | · | -23.7 | -31.6 | |
| P/S | 4.8 | · | · | · | · | · | · | · | · | 72.8 | 50.0 | 45.8 | 246.3 | · | 522.1 | 636.3 | |
| P/B | 6.9 | 5.7 | · | -38.0 | 7.1 | -9.6 | · | 10.9 | · | 11.9 | 2.5 | 1.8 | 30.6 | · | 34.1 | 48.5 | |
| P / Tangible Book | 10.1 | 7.1 | · | · | 12.5 | · | · | 10.9 | · | 11.9 | 2.5 | 1.8 | 30.6 | · | 34.1 | 48.5 | |
| P / Cash Flow | · | -8.9 | · | · | · | -8.0 | · | · | · | -10.5 | · | · | -49.8 | · | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | -10.5 | · | · | · | · | · | · | |
| EV / EBITDA | -6.4 | -6.3 | · | -11.1 | -2.1 | -4.4 | · | -0.2 | · | -7.8 | -5.2 | -0.3 | -47.3 | · | · | · | |
| EV / FCF | · | · | · | · | · | · | · | · | · | -7.7 | · | · | · | · | · | · | |
| EV / Revenue | 2.9 | · | · | · | · | · | · | · | · | 53.2 | 26.9 | 1.3 | 222.8 | · | · | · | |
| Earnings Yield | -72.8% | -64.0% | · | -40.0% | -60.0% | -51.9% | · | -97.7% | -123.8% | -29.3% | -28.2% | -22.3% | -7.5% | · | -4.2% | -3.2% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $31M | $10M | — | $3M | $2M |
| Betriebsgewinnmarge % | -550.3% | -1149.6% | — | -2809.6% | -2991.2% |
| Nettoergebnis | $-209M | $-131M | $-87M | $-74M | $-71M |
| Verwässerte EPS | $-3.02 | $-3.66 | $-3.96 | $-4.57 | $-4.90 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 3.1 | 3.1 | 5.4 | 4.3 | 5.7 |
| Quick Ratio | 2.8 | 2.9 | 3.0 | 3.5 | 1.1 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | — | $-105M | — | — | $-54M |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 174 Einreicher · $309.3M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 41 (0 vs. Vorquartal) | 29 (+9 vs. Vorquartal) | 59 (-8 vs. Vorquartal) | 39 (+9 vs. Vorquartal) | +12.4M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | $26.831.680 | 7.024.000 | 8,68% | Aktien |
| RTW INVESTMENTS, LP | $25.348.729 | 6.635.793 | 8,20% | Aktien |
| Deep Track Capital, LP | $21.930.047 | 5.740.850 | 7,09% | Aktien |
| STATE STREET CORP | $19.611.341 | 5.133.859 | 6,34% | Aktien |
| Rosalind Advisors, Inc. | $15.228.464 | 3.986.509 | 4,92% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $14.712.761 | 3.851.508 | 4,76% | Aktien |
| Nantahala Capital Management, LLC | $13.694.012 | 3.584.820 | 4,43% | Aktien |
| Stonepine Capital Management, LLC | $12.795.575 | 3.349.627 | 4,14% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $12.479.443 | 3.266.870 | 4,04% | Aktien |
| Foresite Capital Management VI LLC | $12.020.130 | 3.146.631 | 3,89% | Aktien |
| BAKER BROS. ADVISORS LP | $9.547.471 | 2.499.338 | 3,09% | Aktien |
| Alyeska Investment Group, L.P. | $8.746.368 | 2.289.625 | 2,83% | Aktien |
| GOLDMAN SACHS GROUP INC | $8.672.133 | 2.270.192 | 2,80% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $7.937.971 | 2.078.003 | 2,57% | Aktien |
| Opaleye Management Inc. | $6.876.000 | 1.800.000 | 2,22% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $6.742.511 | 1.764.564 | 2,18% | Aktien |
| Balyasny Asset Management L.P. | $6.442.717 | 1.686.575 | 2,08% | Aktien |
| Qube Research & Technologies Ltd | $6.220.824 | 1.628.488 | 2,01% | Aktien |
| ACORN CAPITAL ADVISORS, LLC | $5.612.164 | 1.469.153 | 1,81% | Aktien |
| NEXTBio Capital Management LP | $4.991.976 | 1.306.800 | 1,61% | Aktien |
| FRANKLIN RESOURCES INC | $4.221.180 | 1.105.021 | 1,36% | Aktien |
| Pinnacle Financial Partners, Inc. | $4.124.148 | 1.079.620 | 1,33% | Aktien |
| BANK OF AMERICA CORP /DE/ | $3.152.921 | 825.372 | 1,02% | Aktien |
| TWO SIGMA ADVISERS, LP | $3.080.218 | 398.992 | 1,00% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $2.547.459 | 666.874 | 0,82% | Aktien |
| J. Goldman & Co LP | $2.483.283 | 650.074 | 0,80% | Aktien |
| SPHERA FUNDS MANAGEMENT LTD. | $2.416.654 | 632.632 | 0,78% | Aktien |
| FMR LLC | $2.392.306 | 626.258 | 0,77% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $2.356.413 | 616.862 | 0,76% | Aktien |
| XTX Topco Ltd | $2.146.042 | 561.791 | 0,69% | Aktien |
| BlackRock, Inc. | $2.055.099 | 537.984 | 0,66% | Aktien |
| Jefferies Financial Group Inc. | $1.896.741 | 496.529 | 0,61% | Aktien |
| Torray Investment Partners LLC | $1.823.878 | 477.455 | 0,59% | Aktien |
| AIGH Capital Management LLC | $1.791.576 | 468.999 | 0,58% | Aktien |
| TORONTO DOMINION BANK | $1.758.778 | 460.413 | 0,57% | Aktien |
| Exome Asset Management LLC | $1.638.937 | 429.041 | 0,53% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.585.300 | 415.000 | 0,51% | Verkaufsoption |
| Palo Alto Investors LP | $1.182.997 | 309.685 | 0,38% | Aktien |
| Jump Financial, LLC | $1.174.650 | 307.500 | 0,38% | Aktien |
| Virtus Investment Advisers, LLC | $1.083.467 | 283.630 | 0,35% | Aktien |
| Diametric Capital, LP | $1.014.358 | 265.539 | 0,33% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $931.889 | 243.950 | 0,30% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $910.799 | 238.429 | 0,29% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $877.656 | 229.753 | 0,28% | Aktien |
| CITADEL ADVISORS LLC | $872.507 | 228.405 | 0,28% | Aktien |
| Ikarian Capital, LLC | $816.965 | 213.865 | 0,26% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $758.423 | 198.540 | 0,25% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $620.577 | 117.090 | 0,20% | Aktien |
| Knott David M Jr | $592.100 | 155.000 | 0,19% | Aktien |
| CANTOR FITZGERALD, L. P. | $534.800 | 140.000 | 0,17% | Aktien |
| CITIGROUP INC | $441.688 | 115.625 | 0,14% | Aktien |
| ExodusPoint Capital Management, LP | $379.082 | 99.236 | 0,12% | Aktien |
| VANGUARD GROUP INC | $367.271 | 47.574 | 0,12% | Aktien |
| Rafferty Asset Management, LLC | $359.859 | 94.204 | 0,12% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $326.228 | 85.400 | 0,11% | Kaufoption |
| RHUMBLINE ADVISERS | $319.642 | 83.678 | 0,10% | Aktien |
| BARCLAYS PLC | $312.939 | 81.921 | 0,10% | Aktien |
| ADAR1 Capital Management, LLC | $289.556 | 75.800 | 0,09% | Aktien |
| Brevan Howard Capital Management LP | $276.141 | 72.383 | 0,09% | Aktien |
| CITADEL ADVISORS LLC | $265.872 | 69.600 | 0,09% | Verkaufsoption |
| BOOTHBAY FUND MANAGEMENT, LLC | $261.827 | 68.541 | 0,08% | Aktien |
| Nuveen Asset Management, LLC | $261.773 | 50.633 | 0,08% | Aktien |
| Man Group plc | $258.221 | 67.597 | 0,08% | Aktien |
| HSBC HOLDINGS PLC | $231.620 | 59.466 | 0,07% | Aktien |
| MetLife Investment Management, LLC | $226.331 | 59.249 | 0,07% | Aktien |
| Jain Global LLC | $211.009 | 55.238 | 0,07% | Aktien |
| ALGERT GLOBAL LLC | $195.966 | 51.300 | 0,06% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $190.824 | 49.954 | 0,06% | Aktien |
| PROFUND ADVISORS LLC | $181.389 | 47.484 | 0,06% | Aktien |
| Quadrature Capital Ltd | $179.471 | 46.982 | 0,06% | Aktien |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $179.059 | 46.874 | 0,06% | Aktien |
| Quantinno Capital Management LP | $177.007 | 46.337 | 0,06% | Aktien |
| ENVESTNET ASSET MANAGEMENT INC | $170.299 | 44.581 | 0,06% | Aktien |
| Cetera Investment Advisers | $165.834 | 43.412 | 0,05% | Aktien |
| MERCER GLOBAL ADVISORS INC /ADV | $163.190 | 42.720 | 0,05% | Aktien |
| Bank of New York Mellon Corp | $160.692 | 42.066 | 0,05% | Aktien |
| Graham Capital Management, L.P. | $153.300 | 40.131 | 0,05% | Aktien |
| Caption Management, LLC | $146.306 | 38.300 | 0,05% | Kaufoption |
| Quantbot Technologies LP | $139.961 | 36.639 | 0,05% | Aktien |
| MORGAN STANLEY | $132.191 | 34.605 | 0,04% | Aktien |
| DIVERSIFIED TRUST CO | $123.175 | 32.245 | 0,04% | Aktien |
| Invesco Ltd. | $119.150 | 31.191 | 0,04% | Aktien |
| Aries Wealth Management | $117.782 | 30.833 | 0,04% | Aktien |
| Vanguard Global Advisers, LLC | $116.586 | 30.520 | 0,04% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $108.870 | 28.500 | 0,04% | Kaufoption |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $107.828 | 19.499 | 0,03% | Aktien |
| NewEdge Wealth, LLC | $106.295 | 27.826 | 0,03% | Aktien |
| Russell Investments Group, Ltd. | $106.031 | 27.757 | 0,03% | Aktien |
| SEI INVESTMENTS CO | $101.696 | 26.622 | 0,03% | Aktien |
| Nuveen, LLC | $101.696 | 26.622 | 0,03% | Aktien |
| CITADEL ADVISORS LLC | $95.500 | 25.000 | 0,03% | Kaufoption |
| JANE STREET GROUP, LLC | $95.118 | 24.900 | 0,03% | Verkaufsoption |
| Verdad Advisers, LP | $92.585 | 24.237 | 0,03% | Aktien |
| WINTON GROUP Ltd | $92.444 | 24.200 | 0,03% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $85.010 | 22.254 | 0,03% | Aktien |
| INTECH INVESTMENT MANAGEMENT LLC | $83.822 | 21.943 | 0,03% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $79.838 | 20.900 | 0,03% | Aktien |
| PRELUDE CAPITAL MANAGEMENT, LLC | $75.151 | 19.673 | 0,02% | Aktien |
| Police & Firemen's Retirement System of New Jersey | $74.051 | 19.385 | 0,02% | Aktien |
| LAZARD ASSET MANAGEMENT LLC | $70.540 | 18.466 | 0,02% | Aktien |
Unternehmensinsider 42 Insider · 16 Führungskräfte · 24 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Robert Forrester | President and CEO | 3. Januar 2019 A | 221.234 | 0 | 0 | $0 |
| Daniel Calkins | Chief Financial Officer | 22. Juni 2026 S | 117.238 | 0 | 6 | $-54.546 |
| Julie B Feder | Chief Financial Officer | 6. April 2018 A | — | 0 | 0 | $0 |
| John B Green | Chief Financial Officer | 1. Januar 2016 A | 2.500 | 0 | 0 | $0 |
| Michael Kauffman | President of Development | 6. Januar 2026 A | 8.666 | 0 | 1 | $-85.500 |
| Matthew Ros | Chief Operating Officer | 1. April 2025 A | 50.000 | 0 | 0 | $0 |
| Frank Neumann | Chief Medical Officer | 6. Januar 2021 A | 150.000 | 0 | 0 | $0 |
| Steven H. Bloom | Chief Strategy Officer | 3. Januar 2019 A | 3.500 | 0 | 0 | $0 |
| Joseph M Lobacki | Executive VP & CCO | 3. Januar 2019 A | 10.700 | 0 | 0 | $0 |
| T. Le Ngocdiep MD, PhD | Chief Medical Officer | 24. September 2018 A | — | 0 | 0 | $0 |
| Joseph Chiapponi | Vice President of Finance | 9. Januar 2017 A | — | 0 | 0 | $0 |
| Gregory Berk | Chief Medical Officer | 9. Januar 2017 A | — | 0 | 0 | $0 |
| Christoph H Westphal | Executive Chairman | 30. Juni 2015 F | 665.224 | 0 | 0 | $0 |
| Monica Singh | General Counsel | 29. Juni 2015 P | 2.000 | 0 | 0 | $0 |
| Joanna Horobin | Chief Medical Officer | 8. Januar 2015 A | 750 | 0 | 0 | $0 |
| Jonathan Pachter | VP, Head of Research | 1. August 2014 F | 62.249 | 0 | 0 | $0 |
| Karin Anna Tollefson | Direktor | 21. Mai 2026 A | 52.666 | 0 | 0 | $0 |
| Paul A. Bunn | Direktor | 21. Mai 2026 A | 44.333 | 0 | 2 | $-137.997 |
| Michelle Robertson | Direktor | 21. Mai 2026 A | 52.666 | 0 | 0 | $0 |
| Anil Kapur | Direktor | 21. Mai 2026 A | 52.666 | 0 | 0 | $0 |
| Brian M Stuglik | Direktor | 21. Mai 2026 A | 137.147 | 0 | 2 | $-11.275 |
| John Johnson | Direktor | 21. Mai 2026 A | 52.666 | 0 | 0 | $0 |
| Eric K Rowinsky | Direktor | 21. Mai 2026 A | 52.666 | 0 | 0 | $0 |
| BAILEY MICHAEL P | Direktor | 21. Mai 2026 A | 108.000 | 0 | 0 | $0 |
| Robert E. Gagnon | Direktor | 16. Dezember 2025 S | 41.678 | 0 | 2 | $-5.394 |
| Lesley Kim Solomon | Direktor | 12. Mai 2022 A | — | 0 | 0 | $0 |
| Bruce Wendel | Direktor | 16. Juni 2020 A | — | 0 | 0 | $0 |
| Alison Frances Lawton | Direktor | 21. Juni 2019 A | 2.500 | 0 | 0 | $0 |
| Louise S. Phanstiel | Direktor | 13. Juni 2017 A | 26.500 | 0 | 0 | $0 |
| Paul A Friedman, M.D. | Direktor | 14. Juni 2016 A | 3.000 | 0 | 0 | $0 |
| SHERWIN STEPHEN A | Direktor | 12. Juni 2015 A | 2.500 | 0 | 0 | $0 |
| TERMEER HENRI A | Direktor | 12. Juni 2015 A | 14.000 | 0 | 0 | $0 |
| Richard Aldrich | Direktor | 10. Juni 2014 A | 408.142 | 0 | 0 | $0 |
| John K Clarke | Direktor | 12. Juni 2013 P | 2.329.121 | 0 | 0 | $0 |
| Deer Management Co. LLC | Direktor | 6. März 2012 A | — | 0 | 0 | $0 |
| Stephen Kraus | Direktor | 6. März 2012 A | 0 | 0 | 0 | $0 |
| ANSBERT GADICKE | Direktor | 6. März 2012 A | 3.740 | 0 | 0 | $0 |
| Longwood Fund, L.P. | 10%-Eigentümer | 24. Januar 2014 J | 1.919.898 | 0 | 0 | $0 |
| CHP III LP | 10%-Eigentümer | 12. Juni 2013 P | 2.329.121 | 0 | 0 | $0 |
| Dan Paterson | — | 3. August 2026 S | 589.940 | 0 | 23 | $-506.018 |
| Gina Consylman | — | 28. Juni 2021 A | — | 0 | 0 | $0 |
| BARBERICH TIMOTHY J | — | 28. Juni 2021 A | 218.000 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 5 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| DEER VII & CO. LTD., DEER VII & CO. L.P., BESSEMER VENTURE PARTNERS VII L.P., BESSEMER VENTURE PARTNERS VII INSTITUTIONAL L.P., BVP VII SPECIAL OPPORTUNITY FUND L.P., DEER MANAGEMENT CO. LLC ×4 Einreichungen | 25. Februar 2014 | — | Erste Einreichung | — | SEC |
| Longwood Fund, L.P. (2), Longwood Fund GP, LLC (2), Christoph Westphal, M.D., Ph.D. (2), Richard Aldrich (2), Michelle Dipp, M.D., Ph.D. (2) ×4 Einreichungen | 20. Februar 2014 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 15. Juli 2013 | — | Erste Einreichung | — | SEC |
| CHP III, L.P. (2), CHP III Management, LLC (2), John K. Clarke (2), Brandon H. Hull (2), John J. Park (2), Charles G. Hadley (2) | 13. Februar 2012 | — | Erste Einreichung | Passive Anlage | SEC |
| MPM BioVentures V, L.P. (2), MPM Asset Management Investors BV5 LLC (2), MPM BioVentures V GP LLC (2), MPM BioVentures V LLC (2), Ansbert Gadicke (2), Luke Evnin (2), Steven St. Peter (2), Todd Foley (2), James Paul Scopa (2), Vaughn M. Kailian (2), John Vander Vort (2) | 10. Februar 2012 | — | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 22 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,42% | 28.720 NS | 30. April 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,12% | 117.456 NS | 30. April 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,01% | 29.304 NS | 31. Mai 2026 | N-PORT |
| RSSL · Global X Funds | 0,01% | 29.041 NS | 30. April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 3.154 NS | 31. Mai 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 2.466 NS | 31. Mai 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 2.492 NS | 31. Mai 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 2.411 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 63 NS | 31. Mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15. Juli 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | — | — | 15. Juli 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15. Juli 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 15. Juli 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15. Juli 2026 | Täglich |
| ITOT · iShares Trust | — | — | 22. Juli 2026 | Täglich |
| IWV · iShares Trust | — | — | 18. August 2026 | Täglich |
| IWO · iShares Trust | — | — | 18. August 2026 | Täglich |
| IWM · iShares Trust | — | — | 18. August 2026 | Täglich |
| IWC · iShares Trust | — | — | 18. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 13. Juli 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | — | — | 20. Juli 2026 | Täglich |
| IDNA · iShares Trust | — | — | 12. August 2026 | Täglich |